| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,660 |
20,450 |
$2.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,391 |
11,528 |
$2.70M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,616 |
8,898 |
$923K |
| A0999 |
Unlisted ambulance service |
694 |
501 |
$571K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,507 |
5,203 |
$447K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
705 |
653 |
$359K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,255 |
3,853 |
$226K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
160 |
159 |
$144K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,023 |
2,843 |
$103K |
| 71046 |
Radiologic examination, chest; 2 views |
1,493 |
1,390 |
$82K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
650 |
514 |
$56K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
797 |
638 |
$56K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
666 |
562 |
$55K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,712 |
3,339 |
$54K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
305 |
289 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,174 |
1,126 |
$50K |
| 71045 |
Radiologic examination, chest; single view |
934 |
867 |
$47K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
529 |
495 |
$39K |
| A0425 |
Ground mileage, per statute mile |
2,116 |
1,657 |
$33K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
303 |
295 |
$29K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,482 |
4,056 |
$20K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
238 |
226 |
$20K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
337 |
319 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
152 |
146 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,060 |
901 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
238 |
205 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,127 |
20,819 |
$4K |
| 80076 |
|
18,975 |
17,525 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,609 |
20,846 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,116 |
4,604 |
$2K |
| 94060 |
|
13 |
12 |
$2K |
| 93296 |
|
109 |
102 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$2K |
| 83690 |
|
3,619 |
3,373 |
$1K |
| 84484 |
|
2,332 |
1,820 |
$961.49 |
| 83735 |
|
1,262 |
974 |
$948.33 |
| 87631 |
|
2,108 |
1,983 |
$683.52 |
| 81001 |
|
6,293 |
5,744 |
$561.05 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
589 |
524 |
$520.74 |
| 36415 |
Collection of venous blood by venipuncture |
10,428 |
8,483 |
$467.91 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
13 |
$435.40 |
| 87632 |
|
305 |
294 |
$418.46 |
| 87581 |
|
2,468 |
2,329 |
$318.97 |
| 81025 |
|
2,253 |
2,138 |
$273.85 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,048 |
7,263 |
$249.90 |
| 86140 |
|
1,070 |
960 |
$154.27 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
26 |
$153.01 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
25 |
$137.08 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
13 |
$128.67 |
| 81003 |
|
1,507 |
1,414 |
$93.39 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
722 |
671 |
$89.99 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
538 |
427 |
$70.18 |
| 83605 |
|
200 |
162 |
$64.82 |
| 85730 |
|
252 |
229 |
$38.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
577 |
499 |
$28.17 |
| 85610 |
|
371 |
325 |
$25.99 |
| 84443 |
Thyroid stimulating hormone (TSH) |
169 |
161 |
$18.41 |
| 80306 |
|
539 |
506 |
$16.44 |
| 82150 |
|
39 |
37 |
$2.66 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
341 |
309 |
$0.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,309 |
1,124 |
$0.36 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
284 |
255 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,984 |
1,022 |
$0.00 |
| 94726 |
|
13 |
12 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
66 |
61 |
$0.00 |
| 94729 |
|
13 |
12 |
$0.00 |
| 84702 |
|
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
52 |
51 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,541 |
2,197 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
234 |
217 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
349 |
233 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
489 |
420 |
$0.00 |
| 87040 |
|
23 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
80 |
51 |
$0.00 |
| 85652 |
|
16 |
15 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
61 |
57 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
27 |
24 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
80 |
78 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
97 |
50 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
47 |
39 |
$0.00 |
| 85379 |
|
13 |
12 |
$0.00 |